Xcout IntelInbiomotion
Inbiomotion is a biotechnology research company based in Barcelona, Spain, that develops a single-gene-based diagnostic test providing objective predictive and prognostic data.
Subscribe to see Inbiomotion’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Inbiomotion at a glance
Inbiomotion is a diagnostics company headquartered in Spain. It has raised at least $4.7M across the 3 funding rounds on record, 2 of them with a disclosed amount. Its most recent funding round closed in January 2021. Xcout tracks 9 named people at Inbiomotion, including Ralf van den Berg (Chief Operating Officer).
Inbiomotion leadership
- Ralf van den BergChief Operating Officer
- Joël Jean-MairetExecutive Chairman
- Prof Rob E. Coleman MD, MBBS, FRCP, FRCPEChairman
- Roger Gomisfounder
- Juan Carlos Tercero, PhDHead of Product Development
- David L. LaceyNon-Executive Director
3 more named people on record for Inbiomotion, with roles, board committees and tenure — see the full roster →
Inbiomotion funding rounds
At least $4.7M raised across the 3 rounds on record (2 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | Undisclosed | 3 named | |
| — | $2.2M | 3 named | |
| Series A | $2.5M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Inbiomotion competitors
A few of Inbiomotion's closest competitors — see the full list of competitors and alternatives →
Biohope is a commercial-stage biotechnology and R&D company based in Madrid, Spain, dedicated to developing precision medicine in vitro diagnostic tools for chronic medical conditions.
Reveal Genomics, S.L. is a biotechnology company founded in 2020 and headquartered in Barcelona, Spain. The company develops innovative genomic tools to improve breast cancer treatment and personalized medicine.
Health in Code is a Spanish company that provides genetic and genomic diagnostic services, including sequencing, bioinformatics, and clinical interpretation. It serves hospitals, clinical laboratories, healthcare professionals, and patients, with a focus on hereditary and rare diseases such as inherited cardiovascular conditions.
IntegraGen develops genomic tests, molecular diagnostic products, and bioinformatics software for researchers, clinicians, and biopharma companies. The company specializes in oncology and genetic diseases, offering next-generation sequencing services, data analysis tools, and biomarker identification to support clinical research and diagnostics.
EcoGenome LLC is a biotechnology company that develops diagnostic tests and kits for cancer, specifically focusing on prostate cancer. The company identifies individual tumor genetic vulnerabilities to help inform precise therapy planning and treatment choices for patients.
Harmonigenic Corp. is a diagnostics and biotechnology company headquartered in Rochester, New York. The company brings radical innovation to personalized precision medicine, focusing on initial diagnostic and treatment decisions.
Get Inbiomotion's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Inbiomotion in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access